Alan B. Lancz & Associates, Inc. Medtronic PLC Transaction History
Alan B. Lancz & Associates, Inc.
- $94.4 Million
- Q4 2023
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 10,948 shares of MDT stock, worth $853,396. This represents 0.95% of its overall portfolio holdings.
Number of Shares
10,948
Previous 11,148
1.79%
Holding current value
$853,396
Previous $873,000
3.21%
% of portfolio
0.95%
Previous 1.0%
Shares
7 transactions
Others Institutions Holding MDT
# of Institutions
2,245Shares Held
1.06BCall Options Held
6.1MPut Options Held
7.84M-
Vanguard Group Inc Valley Forge, PA126MShares$9.84 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY114MShares$8.88 Billion0.23% of portfolio
-
State Street Corp Boston, MA60.1MShares$4.68 Billion0.24% of portfolio
-
Jpmorgan Chase & CO New York, NY31.6MShares$2.47 Billion0.25% of portfolio
-
Capital Research Global Investors Los Angeles, CA30.9MShares$2.41 Billion0.63% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $104B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...